Live Status Check

NCT06664502 Recruiting Status

Real-time enrollment status for this macular degeneration clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 8:49 AM UTC

NCT06664502 Status Summary

NCT NumberNCT06664502
Recruiting StatusRecruiting
ConditionMacular Degeneration
PhaseClinical Trial
Target Enrollment92 participants
Active Locations26 sites in the US
SponsorEyeBiotech Ltd.
Last Updated on CT.govMay 20, 2025 (May 20, 2025)

About NCT06664502 Enrollment Status

As of March 2, 2026: Clinical trial NCT06664502 is currently recruiting participants. This clinical trial study for macular degeneration is actively seeking new participants at 26 locations across the United States. The study is sponsored by EyeBiotech Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06664502

Is NCT06664502 still recruiting?

Yes, NCT06664502 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06664502 recruiting?

This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06664502?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06664502 status last updated?

The official ClinicalTrials.gov record for NCT06664502 was last updated May 20, 2025 (May 20, 2025). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial